Ross J. Portaro net worth and biography

Ross Portaro Biography and Net Worth

Insider of Venus Concept
Ross is an accomplished industry leader and veteran, bringing over 30 years of experience in the healthcare sector to Venus Concept. His vast experience as a leader in sales includes positions at Candela Medica, Lumenis, and Ulthera, Inc. 

Ross holds a B.S. in Commerce from the University of Virginia’s McIntire School of Commerce.

What is Ross J. Portaro's net worth?

The estimated net worth of Ross J. Portaro is at least $33,912.00 as of November 21st, 2022. Mr. Portaro owns 120,000 shares of Venus Concept stock worth more than $33,912 as of December 6th. This net worth evaluation does not reflect any other investments that Mr. Portaro may own. Learn More about Ross J. Portaro's net worth.

How old is Ross J. Portaro?

Mr. Portaro is currently 59 years old. There are 8 older executives and no younger executives at Venus Concept. The oldest executive at Venus Concept is Mr. Kenji Shimizu, Interim Chief Innovation Officer, who is 69 years old. Learn More on Ross J. Portaro's age.

How do I contact Ross J. Portaro?

The corporate mailing address for Mr. Portaro and other Venus Concept executives is 235 YORKLAND BLVD SUITE 900, TORONTO A6, M2J 4Y8. Venus Concept can also be reached via phone at (888) 907-0115 and via email at [email protected] Learn More on Ross J. Portaro's contact information.

Has Ross J. Portaro been buying or selling shares of Venus Concept?

During the past quarter, Ross J. Portaro has bought $13,200.00 in Venus Concept stock. Most recently, on Monday, November 21st, Ross Portaro bought 60,000 shares of Venus Concept stock. The stock was acquired at an average cost of $0.22 per share, with a total value of $13,200.00. Following the completion of the transaction, the insider now directly owns 120,000 shares of the company's stock, valued at $26,400. Learn More on Ross J. Portaro's trading history.

Who are Venus Concept's active insiders?

Venus Concept's insider roster includes Yoni Iger (VP), Ross Portaro (Insider), Domenic Serafino (CEO), and Keith Sullivan (Director). Learn More on Venus Concept's active insiders.

Are insiders buying or selling shares of Venus Concept?

During the last twelve months, Venus Concept insiders bought shares 12 times. They purchased a total of 3,485,282 shares worth more than $2,580,275.22. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 154,284 shares worth more than $40,113.84. The most recent insider tranaction occured on November, 28th when Director Anthony Natale sold 51,428 shares worth more than $13,885.56. Insiders at Venus Concept own 46.3 % of the company. Learn More about insider trades at Venus Concept.

Information on this page was last updated on 11/28/2022.

Ross J. Portaro Insider Trading History at Venus Concept

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/21/2022Buy60,000$0.22$13,200.00120,000View SEC Filing Icon  
5/17/2022Buy10,000$0.85$8,500.0060,000View SEC Filing Icon  
12/16/2021Buy20,000$1.35$27,000.00View SEC Filing Icon  
12/3/2021Buy30,000$1.35$40,500.00View SEC Filing Icon  
See Full Table

Ross J. Portaro Buying and Selling Activity at Venus Concept

This chart shows Ross Portaro's buying and selling at Venus Concept by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Venus Concept Company Overview

Venus Concept logo
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $0.26
Low: $0.26
High: $0.30

50 Day Range

MA: $0.28
Low: $0.16
High: $0.49

2 Week Range

Now: $0.26
Low: $0.15
High: $2.21


8,391 shs

Average Volume

1,399,322 shs

Market Capitalization

$17.60 million

P/E Ratio


Dividend Yield



Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...